Clear cell ependymoma is a type of brain tumor that most often occurs in the supratentorial region, meaning it arises in the cerebral hemispheres. It is characterized by the presence of ependymal cells that feature a distinctive perinuclear halo on microscopic examination. While specific prevalence data is not available, the condition is recognized within the clinical community for its unique histological appearance. Overall, the diagnosis is typically made in the context of neurological symptoms and imaging studies that prompt further investigation.

The clinical presentation of clear cell ependymoma is largely determined by its location within the brain. Patients may experience symptoms related to increased intracranial pressure, such as headaches, nausea, and changes in vision, as well as other neurological deficits that can vary with tumor size and location. Because detailed characteristic findings and a comprehensive list of phenotypes are not available, the specific features can differ between individuals. Not all individuals experience all features, and severity varies considerably.

The precise genetic basis of clear cell ependymoma remains under investigation, and no specific genes have been definitively linked to its development. This suggests that the condition may arise from complex genetic and environmental factors rather than a single inheritable mutation. As inheritance patterns have not been established for clear cell ependymoma, families are encouraged to seek genetic counseling if there are concerns or questions about potential familial implications.